SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection
Carolyn A. Cohen, Athena P. Y. Li, Asmaa Hachim et al. · Nature Communications · 2021
Abstract only
Infectious Diseases
Filters2 filters applied
Status
- Expression of concern
- Corrected
- No notice
- From publisher notices and Retraction Watch. Not checked means nobody has looked yet.
Year
Readable here
Study type
Licence
The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic
Priyanka Shah, Gabriela A. Canziani, Erik P. Carter et al. · Frontiers in Immunology · 2021
Full textCC BY
Experimental Evidence for Enhanced Receptor Binding by Rapidly Spreading SARS-CoV-2 Variants
Charlie Laffeber, Kelly de Koning, Roland Kanaar et al. · Journal of Molecular Biology · 2021
Abstract only
Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation
Florence WJ Chioh, Siew-Wai Fong, Barnaby E Young et al. · eLife · 2021
Full textCC BY
SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation
David W Sanders, Chanelle C Jumper, Paul J Ackerman et al. · eLife · 2021
Full textCC BY
SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis
Armin Bayati, Rahul Kumar, Vincent Francis et al. · Journal of Biological Chemistry · 2021
Abstract only
SARS-CoV-2: from its discovery to genome structure, transcription, and replication
Ayslan Castro Brant, Wei Tian, Vladimir Majerciak et al. · Cell & Bioscience · 2021 · Review
Full textCC BY
Epidemiology of Mucormycosis in India
Hariprasath Prakash, Arunaloke Chakrabarti · Microorganisms · 2021 · Review
Full textCC BY
Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection
Ariel Israel, Yotam Shenhar, Ilan Green et al. · Vaccines · 2021
Abstract only
Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival
Stefania Dispinseri, Massimiliano Secchi, Maria Franca Pirillo et al. · Nature Communications · 2021
Full textCC BY
Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice
Pratima Kumari, Hussin A. Rothan, Janhavi P. Natekar et al. · Viruses · 2021
Full textCC BY
The Role of Th17 Response in COVID-19
Diana Martonik, Anna Parfieniuk-Kowerda, Magdalena Rogalska et al. · Cells · 2021 · Review
Full textCC BY
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
Sebastian Günther, Patrick Y. A. Reinke, Yaiza Fernández-García et al. · Science · 2021
Full textCC BY
Infection With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant Is Associated With Higher Recovery of Infectious Virus Compared to the Alpha Variant in Both Unvaccinated and Vaccinated Individuals
Chun Huai Luo, C Paul Morris, Jaiprasath Sachithanandham et al. · Clinical Infectious Diseases · 2021
Full textCC BY
SARS-CoV-2 infection, neuropathogenesis and transmission among deer mice: Implications for spillback to New World rodents
Anna Fagre, Juliette Lewis, Miles Eckley et al. · PLOS Pathogens · 2021
Abstract only
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis
Angela Choi, Matthew Koch, Kai Wu et al. · Nature Medicine · 2021 · Randomised trial
Full textCC BY
Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021
Amadea Britton, Kara M. Jacobs Slifka, Chris Edens et al. · MMWR. Morbidity and Mortality Weekly Report · 2021
Full textCC BY
Persistence of Pathogens on Inanimate Surfaces: A Narrative Review
Jan Erik Wißmann, Lisa Kirchhoff, Yannick Brüggemann et al. · Microorganisms · 2021 · Review
Full textCC BY
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial
Jean-Claude Tardif, Nadia Bouabdallaoui, Philippe L L'Allier et al. · The Lancet Respiratory Medicine · 2021 · Randomised trial
Abstract only
SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns
Natalia Redondo, Sara Zaldívar-López, Juan J. Garrido et al. · Frontiers in Immunology · 2021 · Review
Full textCC BY